Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription


1 Am J Psychiatry
1 Biol Psychiatry
1 Br J Psychiatry
1 J Abnorm Psychol
1 J Int Neuropsychol Soc
1 PLoS One
1 Psychiatry Res
4 Psychol Med
10 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Psychiatry

  1. ROBERTSON AG, Easter MM, Lin H, Frisman LK, et al
    Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.
    Am J Psychiatry. 2018;175:665-673.
    PubMed     Text format     Abstract available

    Biol Psychiatry

  2. BODKIN JA, Coleman MJ, Godfrey LJ, Carvalho CMB, et al
    Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene.
    Biol Psychiatry. 2019 May 9. pii: S0006-3223(19)31330.
    PubMed     Text format     Abstract available

    Br J Psychiatry

  3. CHAN SKW, Pang HH, Yan KK, Hui CLM, et al
    Ten-year employment patterns of patients with first-episode schizophrenia-spectrum disorders: comparison of early intervention and standard care services.
    Br J Psychiatry. 2019 Jul 9:1-7. doi: 10.1192/bjp.2019.
    PubMed     Text format     Abstract available

    J Abnorm Psychol

  4. COOPER JA, Barch DM, Reddy LF, Horan WP, et al
    Effortful goal-directed behavior in schizophrenia: Computational subtypes and associations with cognition.
    J Abnorm Psychol. 2019 Jul 8. pii: 2019-36970-001. doi: 10.1037/abn0000443.
    PubMed     Text format     Abstract available

    J Int Neuropsychol Soc

  5. BRYCE SD, Rossell SL, Lee SJ, Lawrence RJ, et al
    Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial - Corrigendum.
    J Int Neuropsychol Soc. 2019;25:659-660.
    PubMed     Text format    

    PLoS One

  6. STEPANOVA EV, Kondrashin AV, Sergiev VP, Morozova LF, et al
    Toxoplasmosis and mental disorders in the Russian Federation (with special reference to schizophrenia).
    PLoS One. 2019;14:e0219454.
    PubMed     Text format     Abstract available

    Psychiatry Res

  7. MILLER AP, Gizer IR, Fleming Iii WA, Otto JM, et al
    Polygenic liability for schizophrenia predicts shifting-specific executive function deficits and tobacco use in a moderate drinking community sample.
    Psychiatry Res. 2019;279:47-54.
    PubMed     Text format     Abstract available

    Psychol Med

  8. KUO SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, et al
    Transdiagnostic validity of the MATRICS Consensus Cognitive Battery across the autism-schizophrenia spectrum.
    Psychol Med. 2019 Jul 12:1-10. doi: 10.1017/S0033291719001582.
    PubMed     Text format     Abstract available

  9. TAN S, Zhu X, Fan H, Tan Y, et al
    Who will benefit from computerized cognitive remediation therapy? Evidence from a multisite randomized controlled study in schizophrenia.
    Psychol Med. 2019 Jul 12:1-11. doi: 10.1017/S0033291719001594.
    PubMed     Text format     Abstract available

  10. BORA E
    Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
    Psychol Med. 2019 Jul 9:1-9. doi: 10.1017/S0033291719001685.
    PubMed     Text format     Abstract available

  11. JOYCE DW, Averbeck BB, Frith CD, Shergill SS, et al
    Examining belief and confidence in schizophrenia - ADDENDUM.
    Psychol Med. 2019 Jul 8:1. doi: 10.1017/S0033291719001363.
    PubMed     Text format    

    Schizophr Res

  12. RAJARAJAN P, Flaherty E, Akbarian S, Brennand KJ, et al
    CRISPR-based functional evaluation of schizophrenia risk variants.
    Schizophr Res. 2019 Jul 2. pii: S0920-9964(19)30238.
    PubMed     Text format     Abstract available

  13. PIGNON B, Eaton S, Schurhoff F, Szoke A, et al
    Residential social drift in the two years following a first episode of psychosis.
    Schizophr Res. 2019 Jul 4. pii: S0920-9964(19)30229.
    PubMed     Text format    

  14. DEMMIN DL, Mote J, Beaudette DM, Thompson JL, et al
    Retinal functioning and reward processing in schizophrenia.
    Schizophr Res. 2019 Jul 4. pii: S0920-9964(19)30240.
    PubMed     Text format     Abstract available

  15. NORDGAARD J, Henriksen MG, Berge J, Nilsson LS, et al
    First-rank symptoms and self-disorders in schizophrenia.
    Schizophr Res. 2019 Jul 5. pii: S0920-9964(19)30263.
    PubMed     Text format    

  16. MALHI GS, Bell E
    Transdiagnostic conceptualization: Giving psychosis and mood a personality.
    Schizophr Res. 2019 Jul 6. pii: S0920-9964(19)30228.
    PubMed     Text format    

  17. ADDINGTON J, Shakeel MK, Braun A, Bonneville D, et al
    Metacognition in youth at-risk for psychosis.
    Schizophr Res. 2019 Jul 9. pii: S0920-9964(19)30268.
    PubMed     Text format    

  18. FAN F, Tan Y, Wang Z, Yang F, et al
    Functional fractionation of default mode network in first episode schizophrenia.
    Schizophr Res. 2019 Jul 8. pii: S0920-9964(19)30215.
    PubMed     Text format     Abstract available

  19. DIENEL SJ, Enwright JF 3rd, Hoftman GD, Lewis DA, et al
    Markers of glutamate and GABA neurotransmission in the prefrontal cortex of schizophrenia subjects: Disease effects differ across anatomical levels of resolution.
    Schizophr Res. 2019 Jul 8. pii: S0920-9964(19)30224.
    PubMed     Text format     Abstract available

  20. HAYAKAWA E, Ohgidani M, Fujimura Y, Kanba S, et al
    Cuprizone-treated mice, a possible model of schizophrenia, highlighting the simultaneous abnormalities of GABA, serine and glycine in hippocampus.
    Schizophr Res. 2019 Jul 8. pii: S0920-9964(19)30231.
    PubMed     Text format    

  21. LEE CH, Sinclair D, O'Donnell M, Galletly C, et al
    Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder.
    Schizophr Res. 2019 Jul 8. pii: S0920-9964(19)30247.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.